W BRADFORD MIDDLEKAUFF
CIK 1214501 · CBO, GC and Secretary · last filed 2025-10-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$607.5K
Companies
5
Total Filings
16
Lifetime Open-Market Net
-$99.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tourmaline Bio, Inc. (TRML) Delisted | CBO, GC and Secretary | 8,213 | $47.98 | $394.1K | $0 | 2 | 2025-10-28 |
| Immunovant, Inc. (IMVTW) Delisted | General Counsel | — | — | — | $0 | 2 | 2020-05-18 |
| PDSB | Senior VP, GC and Secretary | 73,770 | $0.69 | $50.9K | $0 | 1 | 2019-03-18 |
| EDGE | Senior VP, GC and Secretary | 1,136 | $49.76 | $56.5K | $94.8K | 8 | 2018-12-31 |
| MEDX | SVP, General Counsel & Sec. | 13,878 | $36.03 | $500.0K | -$194.6K | 2 | 2007-09-05 |
Recent Filings · Page 2 of 2
16 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-15 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2016-08-09 | EDGE | Buy (P) | +10,000 | $94.8K | EDGAR |
| 2016-02-18 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2015-11-18 | EDGE | Grant (A) | — | $0 | EDGAR |
| 2007-09-05 | MEDX | Grant (A) | — | $0 | EDGAR |
| 2007-03-19 | MEDX | Mixed | — | -$194.6K | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.